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ages or means and their 95% confidence intervals. RESULTS: Of the estimated 
8.45 billion outpatient visits in the United States between 2003-2010, 
approximately 22.3 million (0.3%) and 73.6 million (0.9%) were for schizophrenia 
and MDD, respectively. Medicare (35.7% [31.2%-40.4%]) and Medicaid (35.2% 
[31.4%-39.2%]) were most common payers for schizophrenia visits, whereas 
private insurance was most common for MDD (49.6% [46.3%-53.0%]) and GOP 
(52.5% [51.1%-53.9%]) visits. During the previous 12-months, there was a higher 
number of outpatient visits for schizophrenia (11.9 [9.6-14.3]) and MDD (10.9 [9.6-
12.1]) than GOP (4.4 [4.3-4.6]). Primary care physician visits accounted for 17.3% 
[13.4%-22.1%] of schizophrenia, 10.6% [8.2%-13.7%] of MDD, and 46.5% [44.5%-
48.5%] of GOP visits. Psychiatrist visits accounted for 79.7% [73.6%-84.7%] of 
schizophrenia, 89.8% [86.9%-92.1%] of MDD, and 2.0% [1.9%-2.2%] of GOP visits. 
More medications were prescribed at schizophrenia (3.0 [2.8-3.3]) than MDD (2.5 
[2.3-2.6]) or GOP (2.2 [2.1-2.3]) visits. However, medication initiations were less 
frequent at schizophrenia (16.8% [13.6%-20.6%]) and MDD (19.6% [17.3%-22.1%]) 
than GOP (36.4% [35.5%-37.4%]) visits. CONCLUSIONS: The NAMCS and NHAMCS 
data provided a representative characterization of outpatient treatment for 
schizophrenia across different payers in the United States. Outpatient visits for 
schizophrenia differed from MDD or GOP visits across multiple characteristics, 
including payer type, physician specialty, and medication use.  
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OBJECTIVES: To compare the effect of insurance coverage on health-care related 
expenditures among patients with arthritis in the United States. METHODS: A 
cross-sectional analysis was conducted. Subjects were derived from the National 
Medical Expenditures Panel Survey (MEPS) for those whom reported having any 
type of arthritis in 2009. A series of weighted univariate statistics were applied to 
examine patient’s demographic characteristics (gender, race, age, etc.) and 
insurance coverage (private, public, and uninsured). We further employed a 
generalized linear regression model to compare the health-care expenditures 
(inpatient, emergency room, outpatient, prescription drug) among different 
insurance status. All analyses utilized SAS PROC SURVEYs’ application to adjust 
for the complex sampling design employed by MEPS database. RESULTS: There 
were an estimated 55.99 million arthritis patients from 2009 MEPS, in which 8.5 
million (15.1%) had rheumatoid arthritis; 21.2 million (37.7%) had osteoarthritis; 
and 26.5 million (47.2%) had unspecified arthritis. It is estimated that the 
majority of the arthritis patients 34.9 million (62.35%) were covered by private 
insurance, 16.5 million (29.5%) were covered by public plans and about 4.5 
million (8%) were uninsured. The total medical expenditure for patients with 
arthritis in 2009 was $522.6 billion. Total prescription expenditures among 
arthritis patients were $122.1 billion. Per capita medical care expenditures 
among private, public and uninsured arthritis patients averaged $8,751, $12,093 
and $3,730 respectively (P<0.0001). Also, there is a significant difference 
(P<0.0001) in the prescription expenditures among private, public and uninsured 
arthritis patients. Average prescription expenditure is $1982.6, $2991.6 and $748 
respectively. CONCLUSIONS: Our findings indicate that uninsured arthritis 
patients had significant lower costs in total health-care expenditure than 
insured patients. Consistently with other studies, the uninsured have more 
unmet health needs than insured Americans. Such undertreated and/or 
underutilized situation may place uninsured people at risk of a serious disability 
complication.  
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OBJECTIVES: To investigate whether obesity is associated with asthma, asthma-
related and total direct medical costs in elderly individuals in the U.S. using 
pooled 2006-2010 Medical Expenditure Panel Survey (MEPS) data. METHODS: This 
study is a retrospective analysis of MEPS data from 2006-2010. Individuals 65 
years or older were included in the study. Individuals with asthma were 
identified by ICD-9-CM code 493 or clinical classification code 128. Individuals 
with a self-reported body mass index greater than 30 kg/m2 were considered to 
be obese. A logistic regression model was used to assess the relationship 
between obesity and asthma. Both asthma-related and total direct medical costs 
including inpatient, outpatient, prescription medication and office-based 
physician visit costs were analyzed. All costs were reported in 2010 U.S. dollars,. 
Generalized linear models with gamma distribution and log link were used to 
assess the relationship between obesity and direct medical costs. Individual 
comorbidities and socio-demographic covariates were controlled for in all 
models. All analyses were conducted using SAS while accounting for the 
complex survey design of MEPS. RESULTS: Out of 18,305 elderly individuals in 
MEPS data 2006-2010, 978 were identified as having asthma, of which 595 were 
obese. Obese elderly individuals were more likely to suffer from asthma as 
compared to non-obese individuals (odds ratio: 1.649; 95% Confidence 
Interval:1.306–2.081). Annual asthma-related costs for obese and non-obese 
asthmatic individuals were $1,585.88 (±94.10) and $1,611.83 (±84.65); annual total 
(all-cause) costs for obese and non-obese asthmatic individuals were $16,144 
(±910.63) and $14,525 (±876.79), respectively. The cost analysis results were not 
statistically significant. CONCLUSIONS: Elderly obese individuals are at a great 
risk of suffering from asthma. Although total direct medical cost for obese 
asthmatic elderly individuals were greater than those of non-obese asthmatics, 
obesity is not a statistically significant predictor of asthma-related and total 
direct medical costs among elderly individuals with asthma.  
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OBJECTIVES: Our study aimed to examine gender differences in Health-related 
expenditures for patients with arthritis in the US civilian non-institutionalized 
population. METHODS: A cross-sectional analysis was conducted using the 
National Medical Expenditures Panel Survey data (MEPS). Study subjects included 
patients who reported having any type of arthritis in 2009. The dependent 
variables include total and out of pocket medical expenditures (in-patients, out-
patient, emergency department visits); and total and out of pocket prescription 
drugs expenditures. A series of weighted t-statistics statistics were used to test 
the effect of gender on health-related expenditures. To provide national 
estimates, all analyses incorporated sample weights and standard errors 
corrections to adjust for the complex sampling design employed by MEPS. 
RESULTS: There were an estimated 55.988 million arthritis patients from 2009 
MEPS, in which 8.5 million (15.1%) had rheumatoid arthritis; 21.2 million (37.7%) 
had osteoarthritis; and 26.5 million (47.2%) had unspecified arthritis. About 85% 
of the patients were white and 60.4% were females. Female showed significant 
higher total medical expenditures than male ($9,633 vs. $8,874) (p<0.0001). 
Female also showed significant higher out of pocket medical expenditures than 
male. ($1,337 vs. $1,026) (p<0.0001). The results from prescription total 
expenditures also showed significant difference (p<0.0001) between male ($2,097) 
and female ($2,235) arthritis patients. Finally, the results of out of pocket 
prescription expenditures showed a significant difference (p<0.0001) between 
male ($414) and female ($500). CONCLUSIONS: The study indicates that women 
have higher medical care service utilization and higher associated charges than 
men. The findings provide valuable evidence for future implications of women 
health care services.  
 
PHS107  
USING PHONE TRIAGE WITH RISK STRATIFICATION TO INITIATE LOW BACK 
PAIN CARE WITHIN A HEALTH CARE SYSTEM  
Karlen EK 
Fairview Health Services, Saint Paul, MN, USA  
OBJECTIVES: Over 50% of people seeking care for low back pain (LBP) enter 
through primary care. Primary care physicians (PCPs) often have less training in 
assessing and treating LBP than physical therapists and medical spine 
specialists. Nationally, the direct cost to manage LBP has continued to grow and 
the outcomes have worsened. This pilot initiated LBP care with the highest-value 
provider type based on the patient’s risk level to determine if higher-value care 
could be delivered. METHODS: For 2 months, patients calling their primary care 
clinic to schedule an appointment for new LBP were diverted to a nurse line. 
After passing a red-flag screen, the patients were risk stratified using the Keele 
STarT Back tool. Low and medium risk patients immediately received reassure-
ance and education in self-management. Those still wanting to see a clinician 
scheduled with a physical therapist. High risk patients scheduled with medical 
spine specialists. Patients referred to physical therapy were matched to 
therapists capable of delivering evidence-based care for their specific risk level. 
Physical therapists received best-practice guidelines and patient profiles for each 
of the risk levels. Patient improvement was measured with the Oswestry 
Disability Index (ODI). RESULTS: Of the 42 LBP patients referred to physical 
therapy, 90% were matched to physical therapists based on risk level. The 
cumulative average ODI improvement was 39% in 5.5 visits, a .06 QALY 
improvement over the previous care model that delivered an average ODI 
improvement of 27% in 6 visits. Patients receiving care from a medical spine 
specialist were 56% more likely to have appropriate imaging and 50 times less 
likely to be prescribed opioids. Estimated direct medical costs savings were 15-
31% with 41-61% in total cost savings to the community. CONCLUSIONS: Phone 
triaging that includes risk stratification delivers higher-value LBP care than 
traditional care models.  
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OBJECTIVES: To evaluate perceptions of community pharmacists towards medi-
cine pricing issues in the model of practice in Malaysia. METHODS: A qualitative 
approach was adopted. Semi structured interviews were conducted by face to 
face interview. Purposive sampling technique was used to recruit a convenient 
sample of full time community pharmacists practising in the State of Penang, 
Malaysia. All interviews were audio recorded, transcribed verbatim and 
thematically analysed. RESULTS: A total of 11 community pharmacists were 
recruited in this study. Thematic content analysis of the interviews identified 
three main themes: factors causing pharmaceutical price war, potential impact 
of price war, and recommendations to overcome price war. In general, price war 
phenomenon has diminished the profit margin of community pharmacists and 
threatened their survival. Thus the participants were anticipated government 
could control medicine price. The findings in this study also highlighted 
participants were dissatisfied with the unethical practise by pharmaceutical 
company in offering different bonus schemes. The bonus schemes also reported 
as discriminatory as physician were offered better perks compare to community 
